In conclusion, this is the first study that demonstrates moscatilin suppresses HCC metastasis through Akt/NF-κB-mediated uPA down-regulation, highlighting the potential of moscatilin as a future HCC treatment. Here, PLAU is linked to hepatocellular carcinoma.